(Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback